Citi Pharma Limited has taken another significant step toward long-term growth and financial excellence through a strategic collaboration with JS Global Capital Limited.
The company recently welcomed CEO Khalil Usmani and his distinguished team to the Citi Pharma manufacturing facility for a productive and insightful visit. During the meeting with Citi Pharma CEO Rizwan Ahmad, both organizations engaged in detailed discussions focused on financial collaboration, capital market opportunities, expansion strategies, and sustainable business growth.
A major highlight of the visit was the signing of a Strategic Financial Advisory Agreement between the two organizations. This partnership aims to unlock new opportunities in investment banking, fundraising initiatives, IPO planning, REIT structures, and other strategic corporate ventures designed to strengthen the company’s future growth trajectory.
The delegation was also given a tour of Citi Pharma’s state-of-the-art manufacturing facility, showcasing the company’s commitment to quality, innovation, and operational excellence. In addition, both teams participated in a plantation activity that symbolized their shared commitment to sustainability and responsible growth.
This collaboration marks the beginning of a promising partnership built on innovation, strategic leadership, and a shared vision for future success. Citi Pharma Limited continues to position itself as a forward-looking organization dedicated to advancing healthcare while expanding its presence in national and international markets.
